Checkpoint Inhibitors in Malignant Pleural Mesothelioma
0 Bekeken
• 07/02/23
0
0
insluiten
administrator
abonnees
Mark Socinski, MD; Mary Jo Fidler, MD; Roy Herbst, MD, PhD; Geoffrey Oxnard, MD; and Naiyer Rizvi, MD discuss the potential for checkpoint inhibitors, such as pembrolizumab, for malignant mesothelioma. Also discussed is the importance of trials that can be done in the community setting.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties